Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Assets (2020 - 2025)

Historic Current Assets for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $668.4 million.

  • Cellebrite DI's Current Assets rose 3329.28% to $668.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $668.4 million, marking a year-over-year increase of 3329.28%. This contributed to the annual value of $567.6 million for FY2024, which is 3447.46% up from last year.
  • As of Q3 2025, Cellebrite DI's Current Assets stood at $668.4 million, which was up 3329.28% from $606.1 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Current Assets ranged from a high of $668.4 million in Q3 2025 and a low of $233.6 million during Q2 2022
  • Over the past 5 years, Cellebrite DI's median Current Assets value was $374.3 million (recorded in 2023), while the average stood at $393.6 million.
  • As far as peak fluctuations go, Cellebrite DI's Current Assets plummeted by 1574.55% in 2021, and later surged by 4613.8% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Current Assets stood at $273.2 million in 2021, then rose by 8.32% to $295.9 million in 2022, then soared by 42.63% to $422.1 million in 2023, then skyrocketed by 34.47% to $567.6 million in 2024, then grew by 17.76% to $668.4 million in 2025.
  • Its Current Assets was $668.4 million in Q3 2025, compared to $606.1 million in Q2 2025 and $523.5 million in Q1 2025.